The revamped American Heart Association tool offers a surprising look at the issues that make cardiovascular disease the ...

MEG Energy’s narrative has shifted again, with the stock’s fair value held at CA$30.00 per share even as Street opinions diverge around the Cenovus deal. With revenue growth assumptions steady near 10 ...

Despite setbacks, scientists around the world produced amazing discoveries every day, some of which made a big splash while ...

Exagen's latest update to its stock narrative comes with a subtly refreshed price target, driven by a mix of slightly higher growth expectations and a modest uptick in perceived risk. While fair value ...

FORGET decorating the Christmas tree and wrapping presents, this year there’s a new festive stress to contend with… for the ...

According to the report, common long-term health problems among older Americans include: High cholesterol: 55.1% (down from ...

Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm ...

Objective This study aimed to evaluate the prevalence and predictors of cardiovascular disease (CVD), chronic kidney disease ...

Innovative Aerosystems has seen its fair value estimate edge up from $16.47 to $18.83 per share, supported by an outlook that now assumes structurally stronger, though slightly more measured, long ...

In December 2025, Vestjysk Bank A/S was removed from the S&P Global BMI Index, ending its inclusion in this widely tracked global benchmark. This index removal can alter how Vestjysk Bank fits into ...

If you have been wondering whether Badger Meter is a quietly compelling opportunity or a stock that has already run its course, you are not alone. This piece is aimed squarely at that question.

The country music world has lost some iconic names in 2025, and sadly the list kept on growing in December. As we close out ...